Table 1.
Clinical and biochemical characteristics of the study population
| Variables | CAD | Control | p |
|---|---|---|---|
| Sex (M/F) |
168/111 |
180/88 |
0.0913 |
| Age (years) |
69.30 ± 0.7049 |
63.73 ±0.6952 |
< 0.0001 |
| BMI (kg/m2) |
23.18 ±0.1337 |
21.04 ±0.08991 |
<0.0001 |
| Smoke (%) |
12.19 |
5.60 |
0.007 |
| Hypertension (%) |
26.16 |
18.66 |
0.0355 |
| DM (%) |
25.81 |
15.30 |
0.0024 |
| AF (%) |
8.60 |
0 |
< 0.0001 |
| Stroke (%) |
7.17 |
1.12 |
0.0004 |
| High TC (%) |
10.39 |
8.21 |
0.3796 |
| High TG (%) |
13.62 |
7.09 |
0.0125 |
| Low HDL (%) |
28.32 |
38.06 |
0.0155 |
| High LDL (%) |
10.04 |
9.33 |
0.7798 |
| Lp(a) (mg/l) |
265.4 ± 12.43 |
215.9 ± 11.11 |
0.0033 |
| BUN (mmol/l) |
5.898 ± 0.1978 |
5.075 ± 0.1675 |
0.0016 |
| SUA (μmol/l) |
340.6 ± 6.018 |
280.6 ± 6.629 |
< 0.0001 |
| Glu (mmol/l) |
6.549 ± 0.1418 |
6.011 ± 0.1231 |
0.0046 |
| CHOL (mmol/l) |
4.785 ± 0.07130 |
4.821 ± 0.2581 |
0.8885 |
| TG (mmol/l) |
1.567 ± 0.07598 |
1.341 ± 0.04895 |
0.0148 |
| HDL (mmol/l) |
1.256 ± 0.0214 |
1.242 ±0.02509 |
0.6613 |
| LDL (mmol/l) |
2.854 ± 0.05867 |
4.190 ± 1.467 |
0.3377 |
| ApoA1 (g/l) |
1.339 ± 0.02123 |
1.262 ± 0.02484 |
0.0187 |
| ApoB (g/l) | 0.9414 ± 0.01682 | 0.8810 ± 0.01690 | 0.0117 |